Lineage Cell Therapeutics In shares owned by Raymond James & Associates
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Raymond James & Associates
from 13F filings
Historical chart of Raymond James & Associates investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Raymond James & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $30k | 20k | 1.48 |
| 2023-12-31 | $22k | 20k | 1.09 |
| 2023-09-30 | $28k | 24k | 1.18 |
| 2023-06-30 | $34k | 24k | 1.41 |
| 2023-03-31 | $32k | 21k | 1.50 |
| 2022-12-31 | $24k | 20k | 1.17 |
| 2022-09-30 | $24k | 21k | 1.14 |
| 2022-06-30 | $31k | 20k | 1.58 |
| 2022-03-31 | $30k | 20k | 1.53 |
| 2021-12-31 | $41k | 17k | 2.44 |
| 2021-09-30 | $42k | 17k | 2.50 |
| 2021-06-30 | $48k | 17k | 2.85 |
| 2021-03-31 | $40k | 17k | 2.37 |
| 2020-12-31 | $35k | 20k | 1.76 |
| 2020-09-30 | $11k | 11k | 0.98 |
| 2020-06-30 | $10k | 11k | 0.89 |
| 2020-03-31 | $9.0k | 11k | 0.80 |
| 2019-12-31 | $11k | 12k | 0.90 |
| 2019-09-30 | $12k | 12k | 0.98 |
More positions owned by Raymond James & Associates
Home Depot (HD)
View all positions for Raymond James & Associates